This EU Science Quarterly for University of Southern Denmark 2nd Quarter 2014 contains all the essential updates and information on EU research, innovation and education funding. If you have questions about this, or other matters regarding EU funding, you are of course welcome to contact us directly at the South Denmark European Office.
Denmark is the first EU country ready for the Structural Funds
Denmark has made a partnership agreement on the Structural Funds for 2014-2020, the first out of the 28 member states to do so. The agreement points out how the 553,3 million EUR allocated for Denmark should be distributed. The agreement has the following specific focuses:
- Increasing job creation as well as national and regional competitiveness through investments in innovation and business development, driving forward entrepreneurship and support agriculture, fisheries and aquaculture,
- Increasing the inclusion of people on the fringe of the labor market by educating to improve their employability,
- Promoting environmental protection and resource efficiency with a basis in the global reputation of Denmark as a leading green economy.
Denmark has put special emphasis on promoting research and innovation activities in green technology to "support the transformation towards a low-carbon economy", developing the knowledge of the national working force through education and training and improving the connection between businesses, research centres and universities to ensure technology transfers, networking cooperation and cluster creations between Danish companies.
Read more about the agreement here (in Danish).
New interactive system for ranking universities
Decision makers, coming students and all others interested are now able to see which universities are performing best given different criteria with the new ranking system U-Multirank. U-Multirank covers more than 850 institutions, 1.200 faculties and 5.000 study programmes.
The ranking is based on 30 different criteria that might be relevant in order to choose which university a student should attend, and U-Multirank allows the users to decide which peformance criteria it will include in its ranking, which is then tailored their specific needs, e.g. student mobility and occupation among graduates. See how University of Southern Denmark is performing here.
IMI 2 publishes Strategic Research Agenda
The Strategic Research Agenda of the Innovative Medicine Initiative 2 (IMI 2) has been published. Since IMI 2 is a Joint Technology Initiative (JTI) it aims at cooperation in fields where research and technology can contribute to the competitiveness of Europe. Winning consortiums in IMI 2 will cooperate with EFPIA (the European Federation of Pharmaceutical Industries and Associations).
IMI 2 will provide a framework for collaboration between companies, universities, public laboratories, innovative SMEs, patient groups and regulators in order to tackle the challenges that the European healthcare system is facing thus ensuring the international competitiveness of Europe.
The Strategic Research Agenda is called "The right prevention and treatment for the right patient at the right time" and focuses on health related challenges within society today. The Agenda lists four axes of research where multi-stakeholder input is essential for success. The four research objectives are: 1) Target validation and biomarker research, 2) Adoption of innovative clinical trial paradigms, 3) Innovative Medicines, 4) Patient tailored adherence programmes.
IMI 2 is expected to start in 2014 and run for 10 years. Read more here.
Dane Peter Olesen appointed Chairman of EIT
From 1 August 2014 Peter Olesen will succeed Alexander von Gabain as chairman of the EIT Governing Board.
EIT is a European Union body which has the goal of driving forward innovation and entrepreneurship within Europe. The institute hosts Knowledge and Innovation Communities (KICs) which bring together higher education institutions, research labs and companies with the aim of developing new and innovative products, starting companies and training entrepreneurs.
It is expected that Peter Olesen will continue strengthening the existing KICs and will expand the EIT's portfolio with even more KICs in the coming years. The EIT has now launched calls for two new KICs.
EU POLICY AND ADVOCACY
New Green Paper and hearing on mobile health (mHealth)
The European Commission has launched a public consultation on the Green Paper on mobile health to help identify barriers and issues related to the use of mHealth. mHealth includes health services supported by use of mobile devices such as smartphones, tablets and other wireless devices.
The Commission addresses the objective of the consultation to receive feedback from, among others, regional and national authorities, consumer organisations, patient organisations, health employees and health organisations, public authorities, app developers and manufacturers of mobile devices.
Furthermore the Commission has published a Staff Working Document which provides legal guidance on EU legislation in the fields of data protection, medical devices and consumer rights for app developers, medical device manufacturers, digital distribution platforms etc.
The deadline for comments on the hearing is 3 July 2014 and should be done here.
Online consultation on 'game-changing' directions for future research in the technological domain
The Future and Emerging Technologies (FET) Unit of the European Commission has published an online consultation targeting scientists and researchers from a wide range of disciplines. The aim of the consultation is to identify promising and potentially 'game-changing' directions for future research within any technological field. Read more about the background here.
The consultation takes the form of discussions where contributors will have the opportunity to suggest new topics for the 2016-2017 FET Work Programme and also to discuss the relevance of former topics sampled in an earlier consultation. The consultation can be found here, and has a deadline of 15 June 2014.
Swiss institutions not eligible for direct participation in Horizon 2020 funding
As of 26 February Switzerland is no longer considered an associated country in Horizon 2020. This means that Swiss entities may only participate in Horizon 2020 in the same way as any industrialised third country, and is therefore not automatically eligible for funding. Swiss partners will thus not count towards the minimum number of participants required for a project.
The failure to reach an agreement during the negotiations with Switzerland means that projects with Swiss partners will not be able to receive direct funding. For projects involving Swiss partners, you should either:
1. If you have enough partners to comply with eligibility criteria, you should continue, but have the Swiss part outline how it will get its funding. Switzerland has for this matter established a national scheme for the Horizon 2020 projects, or
2. Involve more partners in order to comply with the eligibility criteria.
If you have any questions or concerns regarding this matter you should contact Christian Walther Bruun at email@example.com.
New rules and Swiss ineligibility results in decrease of applications for ERC Starting Grants
In the last edition of EU Science Quarterly, we announced that the submission service was open to applicants for ERC Starting Grants with a deadline for submission of 25 March. The results of the competition has now been published.
In the 2014 competition there was a total of 3272 applications. This means that the demand for the ERC Starting Grants has decreased by 1,7 % compared to the 3329 applications in 2013. This decrease could be due to two reasons:
- The recent introduction of restrictions in re-submissions rules. This may have discouraged researchers whose proposals did not advance to step 2 of the evaluation in the 2013 call because of insufficient quality.
- On 26 February Switzerland was barred from participation in ERC proposals. Given that Swiss researchers usually have a success rate nearly twice as high as the European average, Switzerland is generally recognised as a winning and hosting actor of ERC grants.